Golden Biotechnology Corporation (TPEX:4132)
Taiwan
· Delayed Price · Currency is TWD 23.00
+3.15 (15.87%)
At close: Dec 5, 2025
Golden Biotechnology Cash Flow Statement
Financials in millions TWD. Fiscal year is January - December.
Millions TWD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
|---|---|---|---|---|---|---|---|
Period Ending | Jun '25 Jun 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2019 - 2015 |
| Net Income | -314.93 | -360.7 | -361.64 | -271.88 | -443.84 | -391.38 | Upgrade
|
| Depreciation & Amortization | 43.11 | 44.76 | 49.25 | 49.95 | 49.38 | 54.93 | Upgrade
|
| Other Amortization | 1.82 | 1.57 | 1.78 | 1.26 | 1.81 | 1.98 | Upgrade
|
| Loss (Gain) From Sale of Assets | -0.15 | -0.15 | -1.01 | -0.44 | - | 0.48 | Upgrade
|
| Asset Writedown & Restructuring Costs | 0.04 | - | 1.68 | 2.23 | 10.01 | 27.24 | Upgrade
|
| Loss (Gain) From Sale of Investments | - | - | - | 0.23 | - | 1.22 | Upgrade
|
| Stock-Based Compensation | 24.2 | 24.2 | - | - | 21.7 | - | Upgrade
|
| Provision & Write-off of Bad Debts | - | - | - | - | - | -0.1 | Upgrade
|
| Other Operating Activities | 1.68 | 1.35 | -0.62 | -1.25 | 6.12 | 3.62 | Upgrade
|
| Change in Accounts Receivable | -2.78 | 0.44 | 1.02 | -0.57 | -0.77 | 2.17 | Upgrade
|
| Change in Inventory | 13.77 | 17.33 | -0.5 | 70.53 | 71.74 | 32.31 | Upgrade
|
| Change in Accounts Payable | -0.79 | -1.09 | 0.71 | 0.45 | -0.77 | -0.29 | Upgrade
|
| Change in Unearned Revenue | -1.25 | 1.42 | 2 | -113.82 | 114.13 | 0.01 | Upgrade
|
| Change in Other Net Operating Assets | -0.19 | 7.76 | 36.03 | 17.41 | -27.47 | 8.23 | Upgrade
|
| Operating Cash Flow | -235.48 | -263.11 | -271.32 | -245.9 | -197.96 | -259.6 | Upgrade
|
| Capital Expenditures | -3.51 | -0.94 | -4.89 | -14.4 | -9.34 | -9.42 | Upgrade
|
| Sale of Property, Plant & Equipment | 0.15 | 0.15 | 1.52 | 0.91 | - | - | Upgrade
|
| Sale (Purchase) of Intangibles | -2.48 | -1.87 | -3.09 | -3.64 | -0.81 | -1.24 | Upgrade
|
| Other Investing Activities | -6.49 | -17.66 | -12.19 | 80.6 | -103.87 | -3.47 | Upgrade
|
| Investing Cash Flow | -12.33 | -20.32 | -18.64 | 63.47 | -114.02 | -14.14 | Upgrade
|
| Short-Term Debt Issued | - | 247.2 | - | - | 72 | 50 | Upgrade
|
| Long-Term Debt Issued | - | 76.06 | - | - | - | 13 | Upgrade
|
| Total Debt Issued | 314.45 | 323.26 | - | - | 72 | 63 | Upgrade
|
| Short-Term Debt Repaid | - | -235.73 | - | -2 | - | - | Upgrade
|
| Long-Term Debt Repaid | - | -35.83 | -21.8 | -24.32 | -33.73 | -37.66 | Upgrade
|
| Total Debt Repaid | -335.01 | -271.56 | -21.8 | -26.32 | -33.73 | -37.66 | Upgrade
|
| Net Debt Issued (Repaid) | -20.56 | 51.7 | -21.8 | -26.32 | 38.27 | 25.34 | Upgrade
|
| Issuance of Common Stock | 240 | 240 | - | - | 580 | 539.21 | Upgrade
|
| Financing Cash Flow | 219.44 | 291.7 | -21.8 | -26.32 | 618.27 | 564.55 | Upgrade
|
| Foreign Exchange Rate Adjustments | 0.04 | -0.32 | -0.85 | 0.67 | -2.65 | -0.69 | Upgrade
|
| Net Cash Flow | -28.34 | 7.96 | -312.6 | -208.08 | 303.64 | 290.12 | Upgrade
|
| Free Cash Flow | -238.99 | -264.04 | -276.2 | -260.3 | -207.31 | -269.02 | Upgrade
|
| Free Cash Flow Margin | -536.07% | -645.30% | -435.45% | -119.50% | -253.53% | -302.87% | Upgrade
|
| Free Cash Flow Per Share | -1.49 | -1.75 | -1.94 | -1.83 | -1.56 | -2.14 | Upgrade
|
| Cash Interest Paid | 9.44 | 6.99 | 6.73 | 4.08 | 3.69 | 3.13 | Upgrade
|
| Cash Income Tax Paid | - | 0.2 | 0.91 | 1.37 | 3.92 | 0.44 | Upgrade
|
| Levered Free Cash Flow | -128.7 | -139.01 | -153.2 | -98.85 | -132.66 | -168.97 | Upgrade
|
| Unlevered Free Cash Flow | -122.12 | -133.74 | -148.99 | -96.3 | -130.36 | -166.38 | Upgrade
|
| Change in Working Capital | 8.75 | 25.85 | 39.25 | -26 | 156.86 | 42.42 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.